logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
19/12/2025
Boehringer Ingelheim will acquire Amicus Therapeutics at a cash price of $14.50 per share.
Latest
6 m ago
Huatai Securities (06886.HK): In 2025, it will issue short-term corporate bonds (ninth tranche) to professional investors with a face value interest rate of 1.71%.
6 m ago
Civil Aviation Administration: Strengthening aircraft airworthiness management control.
7 m ago
Moody's rating: As the Federal Reserve prepares to cut interest rates, the default rate of American companies is decreasing but the risk of defaults continues to exist.
7 m ago
Truist Securities: Tesla's long-term value is mainly linked to its ability to commercialize AI-driven products and services, especially its robot taxi platform built with fully autonomous driving technology. The platform is expected to launch in more cities by 2026, but the specific timing is still uncertain, and changes in industry competition may further intensify stock price fluctuations.
7 m ago
China Railway Construction (01186.HK): "Railway Construction YK07" will pay interest on December 29th.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.